CRLBF
Price
$1.14
Change
-$0.04 (-3.39%)
Updated
Sep 4 closing price
Capitalization
404.95M
63 days until earnings call
VRNOF
Price
$1.27
Change
+$0.01 (+0.79%)
Updated
Sep 4 closing price
Capitalization
469.75M
74 days until earnings call
Interact to see
Advertisement

CRLBF vs VRNOF

Header iconCRLBF vs VRNOF Comparison
Open Charts CRLBF vs VRNOFBanner chart's image
Cresco Labs
Price$1.14
Change-$0.04 (-3.39%)
Volume$945.05K
Capitalization404.95M
Verano Holdings
Price$1.27
Change+$0.01 (+0.79%)
Volume$484.42K
Capitalization469.75M
CRLBF vs VRNOF Comparison Chart in %
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. VRNOF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and VRNOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (CRLBF: $1.14 vs. VRNOF: $1.27)
Brand notoriety: CRLBF and VRNOF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRLBF: 75% vs. VRNOF: 52%
Market capitalization -- CRLBF: $404.95M vs. VRNOF: $469.75M
CRLBF [@Pharmaceuticals: Generic] is valued at $404.95M. VRNOF’s [@Pharmaceuticals: Generic] market capitalization is $469.75M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.9B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileVRNOF’s FA Score has 1 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • VRNOF’s FA Score: 1 green, 4 red.
According to our system of comparison, VRNOF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 2 TA indicator(s) are bullish while VRNOF’s TA Score has 3 bullish TA indicator(s).

  • CRLBF’s TA Score: 2 bullish, 5 bearish.
  • VRNOF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VRNOF is a better buy in the short-term than CRLBF.

Price Growth

CRLBF (@Pharmaceuticals: Generic) experienced а -22.97% price change this week, while VRNOF (@Pharmaceuticals: Generic) price change was -23.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

VRNOF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRNOF($470M) has a higher market cap than CRLBF($405M). CRLBF YTD gains are higher at: 24.763 vs. VRNOF (2.008). CRLBF has higher annual earnings (EBITDA): 136M vs. VRNOF (-98.31M). CRLBF has more cash in the bank: 147M vs. VRNOF (68.6M). VRNOF has less debt than CRLBF: VRNOF (509M) vs CRLBF (631M). VRNOF has higher revenues than CRLBF: VRNOF (847M) vs CRLBF (685M).
CRLBFVRNOFCRLBF / VRNOF
Capitalization405M470M86%
EBITDA136M-98.31M-138%
Gain YTD24.7632.0081,233%
P/E RatioN/AN/A-
Revenue685M847M81%
Total Cash147M68.6M214%
Total Debt631M509M124%
FUNDAMENTALS RATINGS
CRLBF: Fundamental Ratings
CRLBF
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFVRNOF
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHLTX26.08N/A
N/A
Diamond Hill Select I
RYMRX22.46N/A
N/A
Guggenheim Multi-Hedge Strategies C
TNVIX18.56N/A
N/A
1290 GAMCO Small/Mid Cap Value I
TRVHX18.65N/A
N/A
Nuveen Mid Cap Value I
JEPRX14.08N/A
N/A
JPMorgan Equity Premium Income R6

VRNOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNOF has been closely correlated with GTBIF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRNOF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNOF
1D Price
Change %
VRNOF100%
+0.79%
GTBIF - VRNOF
79%
Closely correlated
-2.94%
CURLF - VRNOF
78%
Closely correlated
+2.19%
TCNNF - VRNOF
76%
Closely correlated
-3.33%
TSNDF - VRNOF
74%
Closely correlated
-9.57%
CRLBF - VRNOF
72%
Closely correlated
-3.39%
More